Experimental drug suppresses rebound of hepatitis C virus in liver transplant ... EurekAlert (press release) San Francisco — A human monoclonal antibody developed by MassBiologics of the University of Massachusetts Medical School (UMMS) given to patients with chronic hepatitis C virus (HCV) infection undergoing liver transplantation significantly suppressed ... |
